APA (7th ed.) Citation

N, N., N, A., T, T., S, Y., K, I., K, F., . . . M, H. (2024). Efficacy of elotuzumab for multiple myeloma deteriorates after daratumumab: A multicenter retrospective study. Annals of hematology, 103(12), 5681. https://doi.org/10.1007/s00277-024-05705-z

Chicago Style (17th ed.) Citation

N, Nakamura, et al. "Efficacy of Elotuzumab for Multiple Myeloma Deteriorates After Daratumumab: A Multicenter Retrospective Study." Annals of Hematology 103, no. 12 (2024): 5681. https://doi.org/10.1007/s00277-024-05705-z.

MLA (9th ed.) Citation

N, Nakamura, et al. "Efficacy of Elotuzumab for Multiple Myeloma Deteriorates After Daratumumab: A Multicenter Retrospective Study." Annals of Hematology, vol. 103, no. 12, 2024, p. 5681, https://doi.org/10.1007/s00277-024-05705-z.